TaiGen Biopharmaceuticals Holdings Limited (TPEX:4157)
Taiwan
· Delayed Price · Currency is TWD 9.41
-0.04 (-0.42%)
Apr 24, 2025, 1:30 PM CST
TPEX:4157 Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -38.58 | 136.73 | -237.16 | 775.62 | -404.82 | Upgrade
|
| Depreciation & Amortization | 24.77 | 27.48 | 28.46 | 28.74 | 30.86 | Upgrade
|
| Other Amortization | 0.06 | 0.13 | 0.09 | 0.12 | 0.57 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | 0.08 | -0.01 | Upgrade
|
| Asset Writedown & Restructuring Costs | 1.96 | - | 12.06 | - | 2.92 | Upgrade
|
| Loss (Gain) From Sale of Investments | -13.55 | -165.22 | -0.3 | -0.08 | -0.43 | Upgrade
|
| Loss (Gain) on Equity Investments | - | - | - | 23.24 | 113.04 | Upgrade
|
| Stock-Based Compensation | 32.48 | 25 | -4.99 | 40.03 | 14.44 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 7.6 | - | - | - | Upgrade
|
| Other Operating Activities | -63.1 | 1.22 | -60.88 | 40.07 | -20.94 | Upgrade
|
| Change in Accounts Receivable | 1.65 | 1.83 | 260.02 | -272.8 | -5.44 | Upgrade
|
| Change in Inventory | -8.24 | -18.75 | 3.29 | -4.35 | -7.13 | Upgrade
|
| Change in Accounts Payable | 1.96 | 0.66 | -17.33 | 10.49 | -1.49 | Upgrade
|
| Change in Unearned Revenue | -0.15 | -0.15 | -0.16 | -44.41 | 44.06 | Upgrade
|
| Change in Income Taxes | - | - | - | 26.29 | 0.29 | Upgrade
|
| Change in Other Net Operating Assets | 3.37 | -9.05 | -4.37 | -2.68 | -2.26 | Upgrade
|
| Operating Cash Flow | -173.09 | 7.46 | -21.27 | 629.07 | -242.1 | Upgrade
|
| Capital Expenditures | -0.53 | -3.89 | -3.39 | -10.24 | -5.46 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | 0.11 | 0.01 | Upgrade
|
| Sale (Purchase) of Intangibles | -2.16 | -3.51 | -4.07 | -1.6 | -2.95 | Upgrade
|
| Investment in Securities | -136.22 | 138.44 | -81.62 | -298.07 | 216.76 | Upgrade
|
| Other Investing Activities | 28.04 | 14.42 | 4.13 | 3.73 | 7.74 | Upgrade
|
| Investing Cash Flow | -110.87 | 145.46 | -84.95 | -306.07 | 216.1 | Upgrade
|
| Short-Term Debt Issued | - | - | 3 | - | - | Upgrade
|
| Total Debt Issued | - | - | 3 | - | - | Upgrade
|
| Short-Term Debt Repaid | - | -3 | - | - | -30 | Upgrade
|
| Long-Term Debt Repaid | -15.98 | -16.99 | -17.99 | -18.61 | -19.07 | Upgrade
|
| Total Debt Repaid | -15.98 | -19.99 | -17.99 | -18.61 | -49.07 | Upgrade
|
| Net Debt Issued (Repaid) | -15.98 | -19.99 | -14.99 | -18.61 | -49.07 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 0.02 | Upgrade
|
| Other Financing Activities | -1.42 | -1.14 | -0.85 | -0.24 | -0.6 | Upgrade
|
| Financing Cash Flow | -17.4 | -21.12 | -15.84 | -18.85 | -49.65 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.84 | -0.25 | 0.24 | -0.07 | 0.25 | Upgrade
|
| Net Cash Flow | -300.52 | 131.55 | -121.82 | 304.08 | -75.4 | Upgrade
|
| Free Cash Flow | -173.62 | 3.57 | -24.66 | 618.83 | -247.56 | Upgrade
|
| Free Cash Flow Margin | -115.25% | 2.90% | -68.06% | 47.80% | -1056.95% | Upgrade
|
| Free Cash Flow Per Share | -0.24 | 0.01 | -0.03 | 0.86 | -0.34 | Upgrade
|
| Cash Interest Paid | 1.42 | 1.14 | 0.85 | 0.24 | 0.6 | Upgrade
|
| Cash Income Tax Paid | 5.1 | 9.83 | 32.22 | 72.51 | 3.23 | Upgrade
|
| Levered Free Cash Flow | -18.62 | -84.51 | 57.08 | 366.39 | -111.98 | Upgrade
|
| Unlevered Free Cash Flow | -17.73 | -83.8 | 57.61 | 366.55 | -111.61 | Upgrade
|
| Change in Net Working Capital | -3.97 | 19.82 | -215.06 | 252.68 | -43.01 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.